GlassScriptPhysician profile
Naja M Thomas
NPI 1588862452
$578.56
in general payments reported to CMS, 2019-2025
15 companies · $63.34 in 2025
The $63.34 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $123 · 2021: $170 · 2022: $88.21 · 2023: $31.16 · 2025: $63.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $94.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $94.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $167.21 | 2019-2022 | |
| Lilly USA, LLC | $75.72 | 2020-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $54.29 | 2020-2023 | |
| Astrazeneca Pharmaceuticals LP | $47.84 | 2025 | Farxiga, Breztri |
| Abbott Laboratories | $41.05 | 2019-2021 | |
| Eisai INC. | $37.70 | 2021-2022 | |
| Astellas Pharma US INC | $21.26 | 2020 | |
| Insulet Corporation | $20.20 | 2019 | |
| Esperion Therapeutics, INC. | $19.29 | 2020 | |
| Genentech USA, INC. | $18.30 | 2019 | |
| Boston Scientific Corporation | $16.09 | 2022 | |
| Amarin Pharma, INC. | $16.07 | 2019 | |
| Exact Sciences Corporation | $15.08 | 2023 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $14.81 | 2020 | |
| Medtronic, INC. | $13.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naja Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.